Mayne Pharma | MYX - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Mayne Pharma

Mayne Pharma reported AUD290.02M in Net Income for its fiscal semester ending in December of 2022.


Net Income Change
Ansell ANN:AU USD 63.9M 17.6M
Cochlear COH:AU AUD 141.6M 21.8M
CSL CSL:AU USD 1.62B 1.13B
Ecofibre Ltd EOF:AU AUD -17608000 9.63M
Healius Ltd HLS:AU AUD -28700000 103.4M
Integral Diagnostics Ltd IDX:AU AUD 16.14M 11.73M
Medical Developments International Ltd MVP:AU AUD 2.66M 7.69M
Nanosonics Ltd NAN:AU AUD 10.37M 10.5M
Next Science Ltd NXS:AU USD -6094530 494.26K
Polynovo Ltd PNV:AU AUD -3823790 1.01M
Probiotec Ltd PBP:AU AUD 5.46M 3.8M
Ramsay Health Care RHC:AU AUD 194.4M 79.3M
ResMed RMD:AU USD 224.91M 14.44M
Sigma Healthcare Ltd SIG:AU AUD 3.3M 4.79M
Sonic Healthcare SHL:AU AUD 382.35M 250.55M
Telix Pharmaceuticals Ltd TLX:AU AUD -33188000 37.7M